Cure Childhood Cancer

Scientific Advisory Council

If the key to finding the cure for childhood cancer is research, how do we decide which research projects to fund? We look to our 9067-0122Scientific Advisory Council to guide our choices.

Comprised of doctors, scientists and experts, the council studies the status of current research funded by CURE, as well as that funded since 2006. They assess the outcomes and identify successful projects to make funding recommendations that align with CURE’s research goals.

Currently, our focus is on projects aimed at the 20% of children diagnosed with cancer who are not surviving today’s methods of treatment. With that in mind, in fiscal year 2014-2015, we will fund research involving the highest risk pediatric cancers that fall into one of the following categories:

1. Innovative clinical therapy and transplantation

2. Mechanism of drug resistance and drug discovery

3. Study of novel tumor biomarkers for diagnostic, prognostic, therapeutic and
vaccine development potential

4. Genetics and/or Genomics as related to cancer development, resistance,

We’re also interested in projects focused on survivorship that evaluate short-term and long-term consequences of cancer and anti-cancer therapy in patients who are cured, in order to improve the quality of life during and after treatment.

The CURE Scientific Advisory Council includes:

  • Kevin L. Karem, PhD: Scientist – Council Chair
  • Terri Ades, DNP, FNP-BC, AOCN: Director, Cancer Information, American Cancer Society
  • Carlos Alvarado, MD: Emeritus Professor, Emory University
  • John D. Bergsagel, MD, Oncologist at Children’s Healthcare of Atlanta at Scottish Rite and Assistant Professor of Pediatrics, Department of Pediatrics, Emory University School of Medicine
  • Leon Bernal-Mizrachi, MD: Assistant Professor of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
  • William H. Chambers, PhD: Director, Clinical Cancer Research and Immunology, American Cancer Society
  • Harry Findley, PhD: Emeritus Professor, Emory University
  • Howard Katzenstein, MD: Medical Director, Pediatric Hematology Oncology, Vanderbilt University School of Medicine
  • Erwin G. Van Meir, PhD: Professor, Departments of Neurosurgery and Hematology & Medical Oncology; Leader, Winship Cancer Institute Cancer Cell Biology Program; Founding Director, Graduate Program in Cancer Biology; and Director, Laboratory for Molecular Neuro-Oncology, Emory University School of Medicine
  • Edmund “Ned” K. Waller, MD, PhD, FAC: Professor of Medicine and Oncology, and Director, Bone Marrow and Stem Cell Transplant Center, Winship Cancer Institute of Emory University
  • Richard J. Woodcock, MD: Neuroradiologist, MRI & Imaging of Georgia

  • Screen Shot 2015-11-03 at 10.19.07 AM


    Order these personalized holiday cards and invitations from Paper Style and 20% will be donated to CURE. Photo and non-photo options are available, with same-day shipping from Atlanta when ordered by 2pm. Shop now.

  • Screen Shot 2015-11-23 at 3.17.52 PM


    We thank you for considering CURE as part of your tax-deductable charitable giving in 2015. We use every dollar wisely and are honored to be named to the prestigious Daily Parent 2015 Top 5 List of “Pediatric Cancer Charities Who Deserve Your Money Now!” Click here to read the article and click here to make a donation to CURE.